Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation

More than 50% of human tumors display hyperactivation of the serine/threonine kinase AKT. Despite evidence of clinical efficacy, the therapeutic window of the current generation of AKT inhibitors could be improved. Here, we report the development of a second-generation AKT degrader, INY-05-040, whic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Erickson, Emily (VerfasserIn) , You, Inchul (VerfasserIn) , Perry, Grace (VerfasserIn) , Dugourd, Aurélien (VerfasserIn) , Donovan, Katherine A. (VerfasserIn) , Crafter, Claire (VerfasserIn) , Johannes, Jeffrey W. (VerfasserIn) , Williamson, Stuart (VerfasserIn) , Moss, Jennifer I. (VerfasserIn) , Ros, Susana (VerfasserIn) , Ziegler, Robert E. (VerfasserIn) , Barry, Simon T. (VerfasserIn) , Fischer, Eric S. (VerfasserIn) , Gray, Nathanael S. (VerfasserIn) , Madsen, Ralitsa R. (VerfasserIn) , Toker, Alex (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2024
In: Science signaling
Year: 2024, Jahrgang: 17, Heft: 825, Pages: ?
ISSN:1937-9145
DOI:10.1126/scisignal.adf2670
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1126/scisignal.adf2670
Verlag, lizenzpflichtig, Volltext: https://www.science.org/doi/10.1126/scisignal.adf2670
Volltext
Verfasserangaben:Emily C. Erickson, Inchul You, Grace Perry, Aurelien Dugourd, Katherine A. Donovan, Claire Crafter, Jeffrey W. Johannes, Stuart Williamson, Jennifer I. Moss, Susana Ros, Robert E. Ziegler, Simon T. Barry, Eric S. Fischer, Nathanael S. Gray, Ralitsa R. Madsen, Alex Toker

MARC

LEADER 00000caa a22000002c 4500
001 1897525117
003 DE-627
005 20241205160007.0
007 cr uuu---uuuuu
008 240802s2024 xx |||||o 00| ||eng c
024 7 |a 10.1126/scisignal.adf2670  |2 doi 
035 |a (DE-627)1897525117 
035 |a (DE-599)KXP1897525117 
035 |a (OCoLC)1475305602 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Erickson, Emily  |e VerfasserIn  |0 (DE-588)1337692115  |0 (DE-627)1897526229  |4 aut 
245 1 0 |a Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation  |c Emily C. Erickson, Inchul You, Grace Perry, Aurelien Dugourd, Katherine A. Donovan, Claire Crafter, Jeffrey W. Johannes, Stuart Williamson, Jennifer I. Moss, Susana Ros, Robert E. Ziegler, Simon T. Barry, Eric S. Fischer, Nathanael S. Gray, Ralitsa R. Madsen, Alex Toker 
264 1 |c February 2024 
300 |a ? 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 27. Februar 2024 
500 |a Gesehen am 02.08.2024 
520 |a More than 50% of human tumors display hyperactivation of the serine/threonine kinase AKT. Despite evidence of clinical efficacy, the therapeutic window of the current generation of AKT inhibitors could be improved. Here, we report the development of a second-generation AKT degrader, INY-05-040, which outperformed catalytic AKT inhibition with respect to cellular suppression of AKT-dependent phenotypes in breast cancer cell lines. A growth inhibition screen with 288 cancer cell lines confirmed that INY-05-040 had a substantially higher potency than our first-generation AKT degrader (INY-03-041), with both compounds outperforming catalytic AKT inhibition by GDC-0068. Using multiomic profiling and causal network integration in breast cancer cells, we demonstrated that the enhanced efficacy of INY-05-040 was associated with sustained suppression of AKT signaling, which was followed by induction of the stress mitogen-activated protein kinase (MAPK) c-Jun N-terminal kinase (JNK). Further integration of growth inhibition assays with publicly available transcriptomic, proteomic, and reverse phase protein array (RPPA) measurements established low basal JNK signaling as a biomarker for breast cancer sensitivity to AKT degradation. Together, our study presents a framework for mapping the network-wide signaling effects of therapeutically relevant compounds and identifies INY-05-040 as a potent pharmacological suppressor of AKT signaling. 
700 1 |a You, Inchul  |e VerfasserIn  |4 aut 
700 1 |a Perry, Grace  |e VerfasserIn  |4 aut 
700 1 |a Dugourd, Aurélien  |d 1989-  |e VerfasserIn  |0 (DE-588)1219540064  |0 (DE-627)1735481246  |4 aut 
700 1 |a Donovan, Katherine A.  |e VerfasserIn  |4 aut 
700 1 |a Crafter, Claire  |e VerfasserIn  |4 aut 
700 1 |a Johannes, Jeffrey W.  |e VerfasserIn  |4 aut 
700 1 |a Williamson, Stuart  |e VerfasserIn  |4 aut 
700 1 |a Moss, Jennifer I.  |e VerfasserIn  |4 aut 
700 1 |a Ros, Susana  |e VerfasserIn  |4 aut 
700 1 |a Ziegler, Robert E.  |e VerfasserIn  |4 aut 
700 1 |a Barry, Simon T.  |e VerfasserIn  |4 aut 
700 1 |a Fischer, Eric S.  |e VerfasserIn  |4 aut 
700 1 |a Gray, Nathanael S.  |e VerfasserIn  |4 aut 
700 1 |a Madsen, Ralitsa R.  |e VerfasserIn  |4 aut 
700 1 |a Toker, Alex  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Science signaling  |d Washington, DC [u.a.] : Assoc., 2008  |g 17(2024), 825 vom: Feb., Artikel-ID eadf2670, Seite ?  |h Online-Ressource  |w (DE-627)560842708  |w (DE-600)2417226-1  |w (DE-576)278762883  |x 1937-9145  |7 nnas  |a Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation 
773 1 8 |g volume:17  |g year:2024  |g number:825  |g month:02  |g elocationid:eadf2670  |g pages:?  |g extent:?  |a Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation 
856 4 0 |u https://doi.org/10.1126/scisignal.adf2670  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.science.org/doi/10.1126/scisignal.adf2670  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240802 
993 |a Article 
994 |a 2024 
998 |g 1219540064  |a Dugourd, Aurélien  |m 1219540064:Dugourd, Aurélien  |d 910000  |d 912900  |e 910000PD1219540064  |e 912900PD1219540064  |k 0/910000/  |k 1/910000/912900/  |p 4 
999 |a KXP-PPN1897525117  |e 4562038713 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","display":"Erickson, Emily","roleDisplay":"VerfasserIn","given":"Emily","family":"Erickson"},{"role":"aut","roleDisplay":"VerfasserIn","display":"You, Inchul","given":"Inchul","family":"You"},{"family":"Perry","given":"Grace","roleDisplay":"VerfasserIn","display":"Perry, Grace","role":"aut"},{"given":"Aurélien","family":"Dugourd","role":"aut","display":"Dugourd, Aurélien","roleDisplay":"VerfasserIn"},{"display":"Donovan, Katherine A.","roleDisplay":"VerfasserIn","role":"aut","family":"Donovan","given":"Katherine A."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Crafter, Claire","given":"Claire","family":"Crafter"},{"family":"Johannes","given":"Jeffrey W.","roleDisplay":"VerfasserIn","display":"Johannes, Jeffrey W.","role":"aut"},{"given":"Stuart","family":"Williamson","role":"aut","display":"Williamson, Stuart","roleDisplay":"VerfasserIn"},{"given":"Jennifer I.","family":"Moss","role":"aut","roleDisplay":"VerfasserIn","display":"Moss, Jennifer I."},{"family":"Ros","given":"Susana","roleDisplay":"VerfasserIn","display":"Ros, Susana","role":"aut"},{"family":"Ziegler","given":"Robert E.","display":"Ziegler, Robert E.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Barry, Simon T.","roleDisplay":"VerfasserIn","given":"Simon T.","family":"Barry"},{"roleDisplay":"VerfasserIn","display":"Fischer, Eric S.","role":"aut","family":"Fischer","given":"Eric S."},{"display":"Gray, Nathanael S.","roleDisplay":"VerfasserIn","role":"aut","family":"Gray","given":"Nathanael S."},{"given":"Ralitsa R.","family":"Madsen","role":"aut","roleDisplay":"VerfasserIn","display":"Madsen, Ralitsa R."},{"given":"Alex","family":"Toker","role":"aut","roleDisplay":"VerfasserIn","display":"Toker, Alex"}],"title":[{"title":"Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation","title_sort":"Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation"}],"recId":"1897525117","language":["eng"],"note":["Veröffentlicht: 27. Februar 2024","Gesehen am 02.08.2024"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Emily C. Erickson, Inchul You, Grace Perry, Aurelien Dugourd, Katherine A. Donovan, Claire Crafter, Jeffrey W. Johannes, Stuart Williamson, Jennifer I. Moss, Susana Ros, Robert E. Ziegler, Simon T. Barry, Eric S. Fischer, Nathanael S. Gray, Ralitsa R. Madsen, Alex Toker"]},"id":{"doi":["10.1126/scisignal.adf2670"],"eki":["1897525117"]},"origin":[{"dateIssuedDisp":"February 2024","dateIssuedKey":"2024"}],"relHost":[{"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Association for the Advancement of Science"}],"language":["eng"],"recId":"560842708","note":["Gesehen am 13.09.21"],"disp":"Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradationScience signaling","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"?","text":"17(2024), 825 vom: Feb., Artikel-ID eadf2670, Seite ?","volume":"17","issue":"825","pages":"?","year":"2024"},"pubHistory":["1.2008 -"],"title":[{"subtitle":"the signal transduction knowledge environment","title":"Science signaling","title_sort":"Science signaling"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Science and Stanford University Libraries"]},"id":{"issn":["1937-9145"],"zdb":["2417226-1"],"eki":["560842708"]},"origin":[{"publisherPlace":"Washington, DC [u.a.]","dateIssuedDisp":"2008-","dateIssuedKey":"2008","publisher":"Assoc."}]}],"physDesc":[{"extent":"? S."}]} 
SRT |a ERICKSONEMMULTIOMICP2024